Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden

J Neuroimaging. 2024 Jan-Feb;34(1):138-144. doi: 10.1111/jon.13170. Epub 2023 Nov 9.

Abstract

Background and purpose: Thalamic hypometabolism is a consistent finding in brain PET with F-18 fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1). However, the pathophysiology of this metabolic alteration is unknown. We hypothesized that it might be secondary to disturbance of peripheral input to the thalamus by NF1-characteristic peripheral nerve sheath tumors (PNSTs). To test this hypothesis, we investigated the relationship between thalamic FDG uptake and the number, volume, and localization of PNSTs.

Methods: This retrospective study included 22 adult NF1 patients (41% women, 36.2 ± 13.0 years) referred to whole-body FDG-PET/contrast-enhanced CT for suspected malignant transformation of PNSTs and 22 sex- and age-matched controls. Brain FDG uptake was scaled voxelwise to the individual median uptake in cerebellar gray matter. Bilateral mean and left-right asymmetry of thalamic FDG uptake were determined using a left-right symmetric anatomical thalamus mask. PNSTs were manually segmented in contrast-enhanced CT.

Results: Thalamic FDG uptake was reduced in NF1 patients by 2.0 standard deviations (p < .0005) compared to controls. Left-right asymmetry was increased by 1.3 standard deviations (p = .013). Thalamic hypometabolism was higher in NF1 patients with ≥3 PNSTs than in patients with ≤2 PNSTs (2.6 vs. 1.6 standard deviations, p = .032). The impact of the occurrence of paraspinal/paravertebral PNSTs and of the mean PNST volume on thalamic FDG uptake did not reach statistical significance (p = .098 and p = .189). Left-right asymmetry of thalamic FDG uptake was not associated with left-right asymmetry of PNST burden (p = .658).

Conclusions: This study provides first evidence of left-right asymmetry of thalamic hypometabolism in NF1 and that it might be mediated by NF1-associated peripheral tumors.

Keywords: FDG-PET; metabolism; neurofibromatosis type 1; peripheral nerve sheath tumors; thalamus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Fluorodeoxyglucose F18 / metabolism
  • Humans
  • Male
  • Nerve Sheath Neoplasms* / complications
  • Nerve Sheath Neoplasms* / metabolism
  • Nerve Sheath Neoplasms* / pathology
  • Neurofibromatosis 1* / complications
  • Neurofibromatosis 1* / diagnostic imaging
  • Neurofibromatosis 1* / metabolism
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography / methods
  • Retrospective Studies
  • Thalamus / diagnostic imaging
  • Thalamus / pathology
  • Tumor Burden

Substances

  • Fluorodeoxyglucose F18